EUCRU
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
EUCRU
Delisted
EUCRU was delisted on the 26th of April, 2023.
19 hedge funds and large institutions have $18.4M invested in Eucrates Biomedical Acquisition Corp. Unit in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
+5
Holders Change %
+35.71%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
2
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$7.29M |
2 |
BI
BVF Inc
San Francisco,
California
|
-$4.99M |
3 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$436K |
4 |
Citadel Advisors
Miami,
Florida
|
-$100K |
5 |
CS
Clear Street
New York
|
-$90K |